RBC Capital Reaffirms Their Sell Rating on Laurentian Bank (LRCDF)
In a report released yesterday, Darko Mihelic from RBC Capital maintained a Sell rating on Laurentian Bank (LRCDF – Research Report), with a price target of C$25.00.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Mihelic is a 5-star analyst with an average return of 7.2% and a 60.22% success rate. Mihelic covers the Financial sector, focusing on stocks such as Great-West Lifeco, Sagicor Financial, and Bank Of Montreal.
In addition to RBC Capital, Laurentian Bank also received a Sell from National Bank's Gabriel Dechaine in a report issued on May 16. However, yesterday, Jefferies maintained a Hold rating on Laurentian Bank (Other OTC: LRCDF).
The company has a one-year high of $22.57 and a one-year low of $16.46. Currently, Laurentian Bank has an average volume of 8,937.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
RBC sees S&P 500 likely falling from current levels by year-end
-- RBC Capital revealed in a note to clients on Monday that it has revised its year-end 2025 S&P 500 target to 5,730, up from 5,550, but warned that the index is still likely to decline from current levels. 'We expect the path of stocks to be choppy through year-end,' RBC analysts wrote, citing a wide range of potential outcomes and growing downside risks. Despite the target upgrade, RBC stressed that 'our sentiment model... is signaling less robust forward returns' and warned that 'a move to +1 standard deviations above the long-term average has been a reliable signal that the stock market is due for a significant pullback.' RBC sees a broad range of possible outcomes by year-end, from a bull case of 6,400 to a bear case as low as 4,200-4,500. 'The wide gap highlights the high degree of uncertainty and fog in the outlook,' the firm said. RBC's models factor in inflation in the upper 2% range, three Federal Reserve cuts starting in September, and real GDP growth of 1.3% for the year. But the firm warned that rising 10-year yields or disappointing economic data could shift sentiment rapidly. The firm also highlighted weakening interest from non-U.S. investors. 'Tariffs opened a door – an openness to investing in other geographies – that had been closed for quite some time,' analysts noted. Overall, RBC described its stance as 'rather neutral,' emphasizing that 'current pricing in the S&P 500 already reflects the step-up improvement in macro fundamentals.' Still, risks including policy uncertainty and weaker consumer sentiment could drive a correction before year-end. Related articles RBC sees S&P 500 likely falling from current levels by year-end BioNTech soars 15% on cancer drug deal with Bristol Myers Campbell Soup beats Q3 estimates, reaffirms guidance Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
4 hours ago
- Business Insider
Daiichi Sankyo Company (DSKYF) Receives a Buy from Bernstein
Bernstein analyst Miki Sogi maintained a Buy rating on Daiichi Sankyo Company (DSKYF – Research Report) yesterday and set a price target of Yen6,400.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Sogi is an analyst with an average return of -1.9% and a 45.45% success rate. Sogi covers the Healthcare sector, focusing on stocks such as Daiichi Sankyo Company, Astellas Pharma, and Chugai Pharmaceutical Co. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Daiichi Sankyo Company with a $40.43 average price target. The company has a one-year high of $44.64 and a one-year low of $20.15. Currently, Daiichi Sankyo Company has an average volume of 76.67K.
Business Insider
4 hours ago
- Business Insider
J.P. Morgan Sticks to Its Buy Rating for RENK Group AG (R3NK)
In a report released today, David Perry from J.P. Morgan maintained a Buy rating on RENK Group AG (R3NK – Research Report), with a price target of €87.50. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Perry is a 5-star analyst with an average return of 14.9% and a 65.12% success rate. Perry covers the Industrials sector, focusing on stocks such as Rheinmetall, Airbus Group SE, and BAE Systems. In addition to J.P. Morgan, RENK Group AG also received a Buy from Jefferies's Chloe Lemaire in a report issued on May 27. However, on May 15, Warburg Research maintained a Hold rating on RENK Group AG (XETRA: R3NK). The company has a one-year high of €80.41 and a one-year low of €17.71. Currently, RENK Group AG has an average volume of 1.73M. Based on the recent corporate insider activity of 10 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of R3NK in relation to earlier this year.
